Novartis AG
NVS
|
|
| |
|
| Trading Volume | 58,609 |
|
|
120.44 - 92.29 |
| Market Cap Full | $ 255.3B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 0.4% | -4.2% | 1.4% | 0.3% |
| Q2 | - | 11.2% | 9.7% | -3.7% |
| Q3 | - | 8.1% | 1% | -10.1% |
| Q4 | - | -9.2% | -0.6% | 19.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 2.5 | -2.5 | -4.1 | -2.5 | 9.3 | 3.4 | 4.6 | 8.1 | - | - | - | -8 |
| 2023 | |||||||||||
| -0.1 | -7.2 | 9.4 | 11.5 | -6.2 | 4.8 | 4 | -4.2 | 1.4 | -8.1 | 4.6 | 3.2 |
| 2022 | |||||||||||
| -0.6 | 0.6 | 0.3 | 0.3 | 3.3 | -7 | 1.8 | -6.5 | -5.6 | 6.7 | 10.4 | 1.3 |
| 2021 | |||||||||||
| -4.2 | -4.9 | -0.6 | 0.7 | 2.7 | 3.2 | 1.3 | - | -11.5 | 1 | -3.5 | 9.8 |
| 2020 | |||||||||||
| 0.4 | -11.9 | -1.3 | 2.8 | 3.2 | -0.1 | -6 | 4.8 | 1.2 | -10.4 | 16.3 | 4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 1.1 | 1 | 0.9 | 1 |
| Q2 | 1.1 | 0.8 | 1.3 | 0.8 |
| Q3 | 0.9 | 0.7 | 1.2 | 0.8 |
| Q4 | 0 | 0.7 | 7.2 | 0.9 |
| A | 3.04 | 3.17 | 10.6 | 3.5 |